Prostate Cancer Detection from MRI Using Efficient Feature Extraction with Transfer Learning

2024-5-16

Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires

2024-1-25

Basic Insights into Tumor Microenvironment in Prostate Cancer

2024-1-1

Prostate Cancer: Epidemiology, Etiology, Pathogenesis, and Risk Factors

2024-1-1

Surgical Treatment of Prostate Cancer

2024-1-1

Histopathological and Molecular Markers in the Assessment of Prostate Cancer Aggressivity

2024-1-1

Stereotactic Radiotherapy in the Treatment of Prostate Cancer

2024-1-1

Pharmacogenomics and Precision Therapy in Prostate Cancer: Challenges and Perspectives

2024-1-1

Biological Markers of Therapeutic Response in Prostate Cancer

2024-1-1

Genetic Susceptibility to Prostate Cancer

2024-1-1

Robot-Assisted Laparoscopic Radical Prostatectomy

2024-1-1

Treatment of Castration-Resistant Prostate Cancer

2024-1-1

The Use of Apheresis in Personalized Cell-Mediated Treatment of Prostate Cancer

2024-1-1

Hormone Therapy for Advanced Prostate Cancer

2024-1-1

Diagnostic, Prognostic and Theranostic Potential of miRNAs in Prostate Cancer

2024-1-1

Tumor Markers in Early Detection and Monitoring of Prostate Cancer: Recent Advances

2024-1-1

Diagnostic Approaches of Prostate Cancer: When Is a Biopsy Required?

2024-1-1

Perspectives of Immunotherapy in Prostate Cancer

2024-1-1

Oxidative Stress, Redox Signaling, and Apoptosis in Prostate Cancer Development and Progression

2024-1-1

Metabolic Reprogramming As a Prostate Cancer Hallmark

2024-1-1

Epigenomics, Transcriptomics, and Translational Control in Prostate Cancer

2024-1-1

Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors

2024-1-1

Health-Related and Psychosocial Factors Associated with Prostate Cancer Stage at Diagnosis among Males Participating in Alberta’s Tomorrow Project

2023-11-10

Cognitive Dysfunction in Patients Treated with Androgen Deprivation Therapy: A Multimodality Functional Imaging Study to Evaluate Neuroinflammation

2023-10-18

Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso

2022-12-17

The Clinical, Diagnostic, Therapeutic, and Prognostic Characteristics of Brain Metastases in Prostate Cancer: A Systematic Review

2022-11-27

Complications of Extended Pelvic Lymph Node Dissection in Patients Undergoing Minimally Invasive Radical Prostatectomy: Analysis and Risk Factors

2022-10-22

Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer

2022-9-28

Prostate Cancer

2022-9-19

Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue

2022-6-16

Diagnostic Accuracy of Predictive Models in Prostate Cancer: A Systematic Review and Meta-Analysis

2022-6-8

Clinical Features and Body Composition in Men with Hormone-Sensitive Metastatic Prostate Cancer: A Pilot Study Examining Differences by Race

2022-6-2

MRI-Based Radiotherapy Planning to Reduce Rectal Dose in Excess of Tolerance

2022-2-3

Prostate-Specific Antigen Screening According to Health Professional Counseling and Age in the United States

2022-1-6

Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer

2021-11-26

Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America

2021-11-9

Relevance of Interleukins 6 and 8 Single Nucleotide Polymorphisms in Prostate Cancer: A Multicenter Study

2021-7-6

Optimal PSA Threshold for Obtaining MRI-Fusion Biopsy in Biopsy-Naïve Patients

2021-7-1

Implications of Regionalizing Care in the Developing World: Impact of Distance to Referral Center on Compliance to Biopsy Recommendations in a Brazilian Prostate Cancer Screening Cohort

2021-6-22

The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study

2021-4-21

High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy

2021-4-8

Predictive and Prognostic Role of Lipocalin-2 Expression in Prostate Cancer and Its Association with Gleason Score

2021-1-20

A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer

2020-12-16

Clinical, Histopathological, and Prognostic Characteristics of Patients with Prostate Cancer in Lubumbashi, Democratic Republic of Congo

2020-12-9

Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer

2020-8-28

Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells

2020-7-31

Understanding and Improving ¹⁸F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer

2020-4-26

Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI

2020-4-3

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

2020-3-30